- Telehealth visits
- Insurance plan information
Helen Stankiewicz Karita, MD, MS
Infectious Diseases- Telehealth visits
- Insurance plan information
Helen Stankiewicz Karita, MD, MS
Infectious Diseases- Telehealth visits
- Insurance plan information
On this page
About me
Education & training
Board certification
- Infectious Disease, American Board of Internal Med/Infectious Disease
- Internal Medicine, American Board of Internal Medicine
Fellowship
- Infectious Diseases, University of Washington School of Medicine
Residency
- Internal Medicine, Advocate Lutheran General Hospital
Internship
- Internal Medicine, Advocate Lutheran General Hospital
Degree
- MD, Universidad Nacional del Nordeste
Academic title
- Health Sciences Clinical Professor
My expertise
Specialties
Locations
My research
Publications
Showing 1-6 of 58 reviews
- August 27, 20265 out of 5 Stars
Very informative, thorough, and responsive.
- August 25, 20265 out of 5 Stars
Dr. Helen Is the best Doctor I have ever met. She is wonderful. Wish there were more Doctors like her. UCSF is very lucky to have her.
- August 14, 20265 out of 5 Stars
Dr. Helen was attentive to my questions and exhibited a great amount of professionalism which I appreciate very much.
- July 29, 20265 out of 5 Stars
I've seen Dr. Karita before and she is very professional and makes you feel like you are important and shows care for your well-being.
- July 16, 20265 out of 5 Stars
She is a wonderful, caring Doctor
- June 26, 20265 out of 5 Stars
Very caring, concerned, professional, and knowledgeable. I appreciate her explanations of treatment and procedures.
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.